Annex Advisory Services’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.51M Sell
12,459
-529
-4% -$181K 0.08% 109
2026
Q1
$4.57M Buy
12,988
+231
+2% +$82.3K 0.09% 110
2025
Q4
$4.18M Buy
12,757
+1,905
+18% +$604K 0.08% 115
2025
Q3
$3.06M Sell
10,852
-378
-3% -$110K 0.07% 114
2025
Q2
$3.14M Buy
11,230
+85
+0.8% +$24.1K 0.08% 112
2025
Q1
$3.47M Sell
11,145
-4,623
-29% -$1.37M 0.1% 97
2024
Q4
$4.11M Sell
15,768
-2,027
-11% -$601K 0.12% 93
2024
Q3
$5.73M Sell
17,795
-336
-2% -$110K 0.18% 81
2024
Q2
$5.66M Buy
18,131
+3,040
+20% +$893K 0.2% 77
2024
Q1
$4.29M Buy
15,091
+285
+2% +$83.4K 0.15% 83
2023
Q4
$4.26M Buy
+14,806
New +$4.03M 0.18% 82
2023
Q1
Sell
-876
Closed -$230K 244
2022
Q4
$230K Buy
+876
New +$235K 0.01% 221
2022
Q3
Sell
-854
Closed -$208K 241
2022
Q2
$208K Buy
+854
New +$209K 0.02% 236
2021
Q4
Sell
-944
Closed -$201K 251
2021
Q3
$201K Sell
944
-13,457
-93% -$3.1M 0.02% 204
2021
Q2
$3.51M Buy
14,401
+657
+5% +$162K 0.28% 59
2021
Q1
$3.42M Buy
13,744
+764
+6% +$182K 0.33% 56
2020
Q4
$2.98M Buy
12,980
+681
+6% +$157K 0.29% 54
2020
Q3
$3.13M Buy
12,299
+20
+0.2% +$4.96K 0.4% 30
2020
Q2
$2.9M Buy
12,279
+623
+5% +$142K 0.4% 29
2020
Q1
$2.36M Buy
11,656
+1,021
+10% +$223K 0.33% 32
2019
Q4
$2.56M Buy
10,635
+421
+4% +$92.8K 0.31% 42
2019
Q3
$1.98M Buy
10,214
+268
+3% +$51.4K 0.27% 46
2019
Q2
$1.83M Sell
9,946
-65
-0.6% -$11.6K 0.26% 45
2019
Q1
$1.9M Sell
10,011
-146
-1% -$27.9K 0.29% 40
2018
Q4
$1.98M Buy
10,157
+678
+7% +$132K 0.31% 43
2018
Q3
$1.97M Buy
9,479
+457
+5% +$90.1K 0.3% 44
2018
Q2
$1.67M Buy
9,022
+575
+7% +$102K 0.28% 42
2018
Q1
$1.44M Buy
8,447
+897
+12% +$165K 0.26% 44
2017
Q4
$1.31M Buy
7,550
+398
+6% +$70.4K 0.25% 43
2017
Q3
$1.33M Buy
7,152
+367
+5% +$65K 0.27% 33
2017
Q2
$1.17M Buy
6,785
+1,022
+18% +$166K 0.26% 33
2017
Q1
$946K Sell
5,763
-1,127
-16% -$187K 0.24% 36
2016
Q4
$1.01M Buy
6,890
+2,276
+49% +$343K 0.24% 32
2016
Q3
$770K Sell
4,614
-88
-2% -$14.9K 0.2% 40
2016
Q2
$715K Buy
4,702
+96
+2% +$14.9K 0.19% 43
2016
Q1
$691K Sell
4,606
-63
-1% -$9.36K 0.2% 43
2015
Q4
$758K Buy
4,669
+339
+8% +$53.3K 0.22% 32
2015
Q3
$599K Buy
4,330
+928
+27% +$146K 0.19% 36
2015
Q2
$522K Buy
3,402
+847
+33% +$136K 0.17% 38
2015
Q1
$408K Buy
2,555
+577
+29% +$90.9K 0.13% 49
2014
Q4
$315K Buy
+1,978
New +$308K 0.1% 66

Other funds holding AMGN

Annex Advisory Services's AMGN Position: Q2 2026 in Review

Annex Advisory Services reduced its Amgen (AMGN) stake by 4.1% in Q2 2026, selling an estimated $181K and leaving 12,459 shares worth $4.51M. The position accounts for 0.08% of the portfolio, ranked #109.

Annex Advisory Services first reported a position in AMGN in Q4 2014 and has held it in 41 quarters since. The position peaked at $5.73M in Q3 2024. 1,278 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Annex Advisory Services held 12,459 shares of Amgen worth $4.51M as of Q2 2026.
  • Annex Advisory Services sold 529 Amgen shares in Q2 2026, an estimated $181K.
  • Amgen made up 0.08% of Annex Advisory Services's portfolio in Q2 2026, its #109 holding.
  • Annex Advisory Services first reported a position in Amgen in Q4 2014 and has held it in 41 quarters since.
  • Annex Advisory Services's Amgen position peaked at $5.73M in Q3 2024.
  • 1,278 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Annex Advisory Services's 13F filing for Q2 2026, filed 10 Jul 2026.